Articles related to Oncology, Medical

In a cohort of 601 women aged ≥65 years with low-risk breast cancer treated without radiotherapy, the 10-year local recurrence rate was 5.5%, with only 0.5% breast cancer-specific mortality.

Latest clinical trial data suggests active monitoring may be a viable alternative to standard treatment for select low-risk DCIS patients, with comparable quality-of-life outcomes.

The Trop-2-directed antibody-drug conjugate demonstrated a 2.3-month improvement in progression-free survival compared to standard chemotherapy options, offering a new treatment pathway for patients with limited options.

T cell activation by dietary proteins provides a previously unknown mechanism for tumor suppression in the small intestine, with significant implications for clinical nutrition protocols.

Research projects a 30% increase in early-onset cancers by 2030, highlighting the urgent need for adjusted screening protocols and preventive strategies in younger populations.

Recent clinical trials demonstrate significant advances in targeted therapies for NETs, with 177Lu-Dotatate showing particular promise as a first-line treatment option for higher-grade GEP-NETs.